CTI BioPharma Corp. Profile Avatar - Palmy Investing

CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…

Biotechnology
US, Seattle [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of CTIC's Analysis
CIK: 891293 CUSIP: 12648L601 ISIN: US12648L6011 LEI: - UEI: -
Secondary Listings
CTIC has no secondary listings inside our databases.